Scientific Industries, Inc reports Q2 EPS (12c) vs. (33c) last year

Reports Q2 revenue $2.6M vs. $3M last year. Helena Santos, Chief Executive Officer of Scientific Industries, stated, “We are optimistic as we enter the second half of 2024 with strong order pipelines for both our Bioprocessing and our Torbal’s VIVID product lines, stemming from product introductions in both segments – the DOTS MPS and the VIVID WORKSTATION, which received tremendous positive feedback from customers at recent trade shows. These opportunities, together with the cost-saving initiatives that have successfully reduced cash burn and operating expenses, which led to significantly improved results, positions us well for financial stability in our core business and allow us to continue advancing our Bioprocessing strategy.”